<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04745962</url>
  </required_header>
  <id_info>
    <org_study_id>00083498</org_study_id>
    <nct_id>NCT04745962</nct_id>
  </id_info>
  <brief_title>Thin EBUS Pilot Study</brief_title>
  <official_title>Clinical Evaluation of the Thin TCP-EBUS Bronchoscopy System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Olympus Medical Systems Corp., Tokyo, Japan.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single-center pilot study at the Medical University of South Carolina (MUSC) to&#xD;
      evaluate the safety and efficacy of the TCP-EBUS scope (Thin EBUS). This study will consist&#xD;
      of a standard of care bronchoscopy and will be followed for approximately 3 months. While the&#xD;
      device is not FDA approved, it is the same technology but a thinner version of the SCP-EBUS&#xD;
      bronchoscope.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 9, 2020</start_date>
  <completion_date type="Anticipated">December 9, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 8, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ability to visualize lung nodule</measure>
    <time_frame>Throughout the procedure (approximately 1 hour)</time_frame>
    <description>Study team will determine whether or not the lung nodule was able to be visualized by the scope.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Lung; Node</condition>
  <arm_group>
    <arm_group_label>Procedural group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Slimscope</intervention_name>
    <description>Slimscope thin EBUS endoscope is inserted and used to visualize lung nodules.</description>
    <arm_group_label>Procedural group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of patients who are scheduled for standard of care&#xD;
        assessment of central pulmonary nodules.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Willing and able to provide informed consent.&#xD;
&#xD;
          2. &gt;21 years of age or older.&#xD;
&#xD;
          3. Target lesion(s) within the middle third of the lung, which will be determined&#xD;
             radiographically prior to scheduling the procedure by the bronchoscopist or&#xD;
             radiologist, or by being located at least 2 airway generations from the main carina as&#xD;
             seen radiographically.&#xD;
&#xD;
          4. Target lesion(s) location documented on CT scan report.&#xD;
&#xD;
          5. Indicated for bronchosocpy.&#xD;
&#xD;
          6. Bronchoscopic procedure scheduled within 30 days of the CT scan report.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Not suitable for flexible bronchoscopy as determined by the treating physician prior&#xD;
             to the procedure.&#xD;
&#xD;
          2. Currently on anticoagulation medications with INR &gt;1.5.&#xD;
&#xD;
          3. Currently using DOAC and does not suspend use at least 7 days prior to the index&#xD;
             procedure&#xD;
&#xD;
          4. Currently using Plavix and does not suspend use for at least 7 days prior to the index&#xD;
             procedure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Nicholas J Pastis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael F Balassone, BS</last_name>
    <phone>843-792-6696</phone>
    <email>Balassom@musc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael F Balassone, B</last_name>
      <phone>843-792-6696</phone>
      <email>Balassom@musc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>February 4, 2021</study_first_submitted>
  <study_first_submitted_qc>February 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2021</study_first_posted>
  <last_update_submitted>October 14, 2021</last_update_submitted>
  <last_update_submitted_qc>October 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Nicholas Pastis</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

